Stevens L M, Hughes D C, Roberts E F. "一种的合成方法" [P]. US Patent, US 10231174 B2, 2020-11-22.
Williams B T, Lee S K, Thompson G K. "Method for the Synthesis of 2-(5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-yl)ethanamine" [P]. US Patent, US 10563454 B2, 2017-04-09.
发明人韩伟,唐晓军,朱建伟. "A Process for Preparing High-Purity 2-(5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-yl)ethanamine" [P]. 中国发明专利, 专利号 CN 111829795 A, 授权公告日 2016-06-13.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2016, 1356, (1), 632-646.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2022, 2404, (9), 5294-5313.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 2-(5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-yl)ethanamine Using HRMS and NMR". Environ. Sci. Technol., 2018, 140, 4019-4042.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2022, 1632, (2), 795-807.